001     299504
005     20250821121532.0
024 7 _ |2 pmid
|a pmid:40022434
024 7 _ |2 ISSN
|a 0014-2956
024 7 _ |2 ISSN
|a 0945-5795
024 7 _ |2 ISSN
|a 1432-1033
024 7 _ |2 ISSN
|a 1742-464X
024 7 _ |2 ISSN
|a 1742-4658
024 7 _ |2 doi
|a 10.1111/febs.70033
024 7 _ |2 altmetric
|a altmetric:175171672
037 _ _ |a DKFZ-2025-00462
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Zuidhof, Hidde R
|b 0
245 _ _ |a The m6A demethylase FTO promotes C/EBPβ-LIP translation to perform oncogenic functions in breast cancer cells.
260 _ _ |a Oxford [u.a.]
|b Wiley-Blackwell
|c 2025
336 7 _ |2 DRIVER
|a article
336 7 _ |2 DataCite
|a Output Types/Journal article
336 7 _ |0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|a Journal Article
|b journal
|m journal
|s 1748247841_9008
336 7 _ |2 BibTeX
|a ARTICLE
336 7 _ |2 ORCID
|a JOURNAL_ARTICLE
336 7 _ |0 0
|2 EndNote
|a Journal Article
500 _ _ |a 2025 May;292(10):2688-2709
520 _ _ |a N6-methyladenosine (m6A) is a prevalent posttranscriptional mRNA modification involved in the regulation of transcript turnover, translation, and other aspects of RNA fate. The modification is mediated by multicomponent methyltransferase complexes (so-called writers) and is reversed through the action of the m6A-demethylases fat mass and obesity-associated (FTO) and alkB homolog 5 (ALKBH5) (so-called erasers). FTO promotes cell proliferation, colony formation and metastasis in models of triple-negative breast cancer (TNBC). However, little is known about genome-wide or specific downstream regulation by FTO. Here, we examined changes in the genome-wide transcriptome and translatome following FTO knockdown in TNBC cells. Unexpectedly, FTO knockdown had a limited effect on the translatome, while transcriptome analysis revealed that genes related to extracellular matrix (ECM) and epithelial-mesenchymal transition (EMT) are regulated through yet unidentified mechanisms. Differential translation of CEBPB mRNA into the C/EBPβ transcription factor isoform C/EBPβ-LIP is known to act in a pro-oncogenic manner in TNBC cells through regulation of EMT genes. Here we show that FTO is required for efficient C/EBPβ-LIP expression, suggesting that FTO has oncogenic functions through regulation of C/EBPβ-LIP.
536 _ _ |0 G:(DE-HGF)POF4-312
|a 312 - Funktionelle und strukturelle Genomforschung (POF4-312)
|c POF4-312
|f POF IV
|x 0
588 _ _ |a Dataset connected to DataCite, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |2 Other
|a C/EBPβ
650 _ 7 |2 Other
|a FTO
650 _ 7 |2 Other
|a breast cancer
650 _ 7 |2 Other
|a mRNA translation
700 1 _ |a Müller, Christine
|b 1
700 1 _ |a Kortman, Gertrud
|b 2
700 1 _ |a Wardenaar, René
|b 3
700 1 _ |0 P:(DE-He78)dc4f734225935c3650fde7619c82ed92
|a Stepanova, Ekaterina
|b 4
700 1 _ |0 P:(DE-He78)4af0380446b05b5f1995502016151a1b
|a Loayza-Puch, Fabricio
|b 5
|u dkfz
700 1 _ |0 0000-0001-6318-7210
|a Calkhoven, Cornelis F
|b 6
773 _ _ |0 PERI:(DE-600)2172518-4
|a DOI:10.1111/febs.70033
|n 10
|p 2688-2709
|t The FEBS journal
|v 292
|x 0014-2956
|y 2025
909 C O |o oai:inrepo02.dkfz.de:299504
|p VDB
910 1 _ |0 I:(DE-588b)2036810-0
|6 P:(DE-He78)dc4f734225935c3650fde7619c82ed92
|a Deutsches Krebsforschungszentrum
|b 4
|k DKFZ
910 1 _ |0 I:(DE-588b)2036810-0
|6 P:(DE-He78)4af0380446b05b5f1995502016151a1b
|a Deutsches Krebsforschungszentrum
|b 5
|k DKFZ
913 1 _ |0 G:(DE-HGF)POF4-312
|1 G:(DE-HGF)POF4-310
|2 G:(DE-HGF)POF4-300
|3 G:(DE-HGF)POF4
|4 G:(DE-HGF)POF
|a DE-HGF
|b Gesundheit
|l Krebsforschung
|v Funktionelle und strukturelle Genomforschung
|x 0
914 1 _ |y 2025
915 _ _ |0 StatID:(DE-HGF)3001
|2 StatID
|a DEAL Wiley
|d 2025-01-03
|w ger
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
|d 2025-01-03
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
|d 2025-01-03
915 _ _ |0 StatID:(DE-HGF)0600
|2 StatID
|a DBCoverage
|b Ebsco Academic Search
|d 2025-01-03
915 _ _ |0 StatID:(DE-HGF)0030
|2 StatID
|a Peer Review
|b ASC
|d 2025-01-03
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Clarivate Analytics Master Journal List
|d 2025-01-03
915 _ _ |0 StatID:(DE-HGF)1050
|2 StatID
|a DBCoverage
|b BIOSIS Previews
|d 2025-01-03
915 _ _ |0 StatID:(DE-HGF)0160
|2 StatID
|a DBCoverage
|b Essential Science Indicators
|d 2025-01-03
915 _ _ |0 StatID:(DE-HGF)1030
|2 StatID
|a DBCoverage
|b Current Contents - Life Sciences
|d 2025-01-03
915 _ _ |0 StatID:(DE-HGF)1190
|2 StatID
|a DBCoverage
|b Biological Abstracts
|d 2025-01-03
915 _ _ |0 StatID:(DE-HGF)0113
|2 StatID
|a WoS
|b Science Citation Index Expanded
|d 2025-01-03
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
|d 2025-01-03
920 1 _ |0 I:(DE-He78)B250-20160331
|k B250
|l B250 NWG Translationskontrolle und Stoffwechsel
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)B250-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21